190 related articles for article (PubMed ID: 15140623)
1. Experimental models of painful diabetic neuropathy.
Calcutt NA
J Neurol Sci; 2004 May; 220(1-2):137-9. PubMed ID: 15140623
[No Abstract] [Full Text] [Related]
2. Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy.
Bordet T; Buisson B; Michaud M; Abitbol JL; Marchand F; Grist J; Andriambeloson E; Malcangio M; Pruss RM
J Pharmacol Exp Ther; 2008 Aug; 326(2):623-32. PubMed ID: 18492948
[TBL] [Abstract][Full Text] [Related]
3. Diabetic neuropathy.
Bloomgarden ZT
Diabetes Care; 2007 Apr; 30(4):1027-32. PubMed ID: 17392563
[No Abstract] [Full Text] [Related]
4. Independent alterations in the central and peripheral somatosensory pathways in rat diabetic neuropathy.
Piriz J; Torres-Aleman I; Nuñez A
Neuroscience; 2009 May; 160(2):402-11. PubMed ID: 19264110
[TBL] [Abstract][Full Text] [Related]
5. [Diabetic neuropathy--a clinical analysis of 202 cases].
Gu YP
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1982 Nov; 15(4):220-4. PubMed ID: 6305601
[No Abstract] [Full Text] [Related]
6. The preventive and therapeutic effects of GCPII (NAALADase) inhibition on painful and sensory diabetic neuropathy.
Zhang W; Murakawa Y; Wozniak KM; Slusher B; Sima AA
J Neurol Sci; 2006 Sep; 247(2):217-23. PubMed ID: 16780883
[TBL] [Abstract][Full Text] [Related]
7. Ameliorating human diabetic neuropathy: lessons from implanting hematopoietic mononuclear cells.
Malik RA; Veves A; Tesfaye S
Exp Neurol; 2006 Sep; 201(1):7-14. PubMed ID: 16808913
[No Abstract] [Full Text] [Related]
8. Pain behavior and nerve electrophysiology in the CCI model of neuropathic pain.
Gabay E; Tal M
Pain; 2004 Jul; 110(1-2):354-60. PubMed ID: 15275786
[TBL] [Abstract][Full Text] [Related]
9. [Electrophysiological findings in peripheral neuropathy].
Kayed K
Tidsskr Nor Laegeforen; 1979 Sep; 99(26):1234-6. PubMed ID: 227131
[No Abstract] [Full Text] [Related]
10. Multiple role of peripheral neuropathy in the pathogenesis of the so-called "diabetic foot". Clinical and electromyographical (EMG) study of 42 cases of "mutilating acropathy".
Negrin P; Fardin P
Electromyogr Clin Neurophysiol; 1986; 26(7):533-40. PubMed ID: 3028760
[No Abstract] [Full Text] [Related]
11. Phrenic neuropathy in patients with diabetes mellitus.
Wolf E; Shochina M; Fidel Y; Gonen B
Electromyogr Clin Neurophysiol; 1983; 23(6):523-30. PubMed ID: 6315336
[No Abstract] [Full Text] [Related]
12. Sensory profiles: A new strategy for selecting patients in treatment trials for neuropathic pain.
Cruccu G; Truini A
Pain; 2009 Nov; 146(1-2):5-6. PubMed ID: 19625126
[No Abstract] [Full Text] [Related]
13. Clinical and electrophysiological correlations in type 2 diabetes mellitus at diagnosis.
Rota E; Quadri R; Fanti E; Poglio F; Paolasso I; Ciaramitaro P; Cossa FM; Cocito D
Diabetes Res Clin Pract; 2007 Apr; 76(1):152-4. PubMed ID: 16962681
[TBL] [Abstract][Full Text] [Related]
14. Small fiber neuropathy: A burning problem.
Tavee J; Zhou L
Cleve Clin J Med; 2009 May; 76(5):297-305. PubMed ID: 19414545
[TBL] [Abstract][Full Text] [Related]
15. A survey of treatment practices in diabetic peripheral neuropathy.
Possidente CJ; Tandan R
Prim Care Diabetes; 2009 Nov; 3(4):253-7. PubMed ID: 19805013
[TBL] [Abstract][Full Text] [Related]
16. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis.
Leonelli E; Bianchi R; Cavaletti G; Caruso D; Crippa D; Garcia-Segura LM; Lauria G; Magnaghi V; Roglio I; Melcangi RC
Neuroscience; 2007 Feb; 144(4):1293-304. PubMed ID: 17187935
[TBL] [Abstract][Full Text] [Related]
17. [Antidromic sensory conduction rate of the ulnar nerve i normal and pathological conditions].
Messina C; Scuderi D
Riv Neurol; 1970; 40(5):336-44. PubMed ID: 4323247
[No Abstract] [Full Text] [Related]
18. [Electrophysiology in diabetic neurological complications].
Kamitani T; Kuroiwa Y
Nihon Rinsho; 1997 Oct; 55 Suppl():855-63. PubMed ID: 9392208
[No Abstract] [Full Text] [Related]
19. Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study.
Papanas N; Giassakis G; Papatheodorou K; Papazoglou D; Monastiriotis C; Christakidis D; Piperidou H; Maltezos E
J Diabetes Complications; 2007; 21(6):353-8. PubMed ID: 17967706
[TBL] [Abstract][Full Text] [Related]
20. Conduction velocity distribution: early diagnostic tool for peripheral neuropathies.
Kiziltan E; Dalkilic N; Guney FB; Pehlivan F
Int J Neurosci; 2007 Feb; 117(2):203-13. PubMed ID: 17365108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
